TDP2
Tyrosyl-DNA phosphodiesterase 2
Also known as: TTRAP, TYDP2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95551
- Gene
- TDP2
- Ensembl
- ENSG00000111802
- Chromosome
- 6
- Canonical length
- 362 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a member of a superfamily of divalent cation-dependent phosphodiesterases. The encoded protein associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor associated factors (TRAFs), and inhibits nuclear factor-kappa-B activation. This protein has sequence and structural similarities with APE1 endonuclease, which is involved in both DNA repair and the activation of transcription factors. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
362 residues, UniProt reviewed canonical sequence.
>O95551|TDP2
1 MELGSCLEGG REAAEEEGEP EVKKRRLLCV EFASVASCDA AVAQCFLAEN DWEMERALNS
61 YFEPPVEESA LERRPETISE PKTYVDLTNE ETTDSTTSKI SPSEDTQQEN GSMFSLITWN
121 IDGLDLNNLS ERARGVCSYL ALYSPDVIFL QEVIPPYYSY LKKRSSNYEI ITGHEEGYFT
181 AIMLKKSRVK LKSQEIIPFP STKMMRNLLC VHVNVSGNEL CLMTSHLEST RGHAAERMNQ
241 LKMVLKKMQE APESATVIFA GDTNLRDREV TRCGGLPNNI VDVWEFLGKP KHCQYTWDTQ
301 MNSNLGITAA CKLRFDRIFF RAAAEEGHII PRSLDLLGLE KLDCGRFPSD HWGLLCNLDI
361 ILLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TDP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 173 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 173 nTPM
- colon: 133 nTPM
- rectum: 120 nTPM
- duodenum: 113 nTPM
- kidney: 73 nTPM
- prostate: 53 nTPM
Single-cell type
- enterocytes: 657 nCPM
- colonocytes: 527 nCPM
- neutrophils: 337 nCPM
- goblet cells: 222 nCPM
- early spermatids: 197 nCPM
- enteric transient amplifying cells: 156 nCPM
Immune cell
- neutrophil: 230 nTPM
- basophil: 76 nTPM
- T-reg: 32 nTPM
- MAIT T-cell: 31 nTPM
- eosinophil: 29 nTPM
- NK-cell: 29 nTPM
Brain region
- thalamus: 34 nTPM
- choroid plexus: 29 nTPM
- cerebellum: 29 nTPM
- midbrain: 27 nTPM
- cerebral cortex: 27 nTPM
- hypothalamus: 26 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TDP2.
Disease | AllUniProt
Conditions TDP2 is implicated in, by any mechanism.
- Spinocerebellar ataxia, autosomal recessive, 23 (SCAR23) MIM:616949
Disease | GeneticClinVar
14 pathogenic / likely-pathogenic of 112 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Spinocerebellar ataxia, autosomal recessive 23
- Sarcoma
- Cerebellar ataxia
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.13
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.11
- DepMap mean gene effect
- -0.25
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- magnesium ion binding
- manganese ion binding
- nuclease activity
- single-stranded DNA binding
- transcription corepressor activity
- 5'-tyrosyl-DNA phosphodiesterase activity
- tyrosyl-RNA phosphodiesterase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TDP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TDP2 as an antibody target. Whether an autoantibody or antibody against TDP2 could matter depends on whether native TDP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TDP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TDP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...